Design and Synthesis of Novel Diarylpyrimidine Derivatives as Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency and Metabolic Stability — Xinyong Liu (2024) | RDL Network
Design and Synthesis of Novel Diarylpyrimidine Derivatives as Hiv-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency and Metabolic Stability
Discussion(0)
No comments yet. Be the first to comment.